Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JAK Caliper Enzyme Assay from US Patent US11197867: "Aminopyrimidinyl compounds"
Assay data:113 Active, 112 Activity ≤ 1 µM, 113 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
JAK Caliper Enzyme Assay at 1 mM ATP from US Patent US10980815: "Aminopyrimidinyl compounds"
Caliper Enzyme Assay from US Patent US10463675: "Aminopyrimidinyl compounds"
Caliper Enzyme Assay from US Patent US9663526: "Aminopyrimidinyl compounds"
Inhibition of JAK1/TYK2 in human whole blood assessed as cytokine inhibition profile by flow cytometric analysis relative to control
Assay data:10 Active, 10 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of JAK1/TYK2 in human whole blood assessed as free fraction of IFNalpha-induced STAT phosphorylation by flow cytometry
Inhibition of JAK1/JAK2 in human whole blood assessed as free fraction of of IL27-induced STAT3 phosphorylation by flow cytometry
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of human recombinant VEGFR2 in presence of substrate Ulight-CAGAGAIETDKEYYTVKD and Km ATP
Inhibition of TYK2/JAK2 in human whole blood assessed as free fraction of of IL23-induced STAT3 phosphorylation by flow cytometry
Inhibition of TYK2/JAK2 in human whole blood assessed as free fraction of of IL12-induced STAT4 phosphorylation by flow cytometry
Inhibition of JAK1/TYK2 in human whole blood assessed as free fraction of IL10-induced STAT3 phosphorylation by flow cytometry
Inhibition of JAK1/JAK3 in human whole blood assessed as free fraction of IL21-induced STAT3 phosphorylation by flow cytometry
Inhibition of JAK1/JAK3 in human whole blood assessed as free fraction of IL15-induced STAT5 phosphorylation by flow cytometry
Inhibition of JAK1/JAK2 in human whole blood assessed as free fraction of IFNgamma-induced STAT phosphorylation by flow cytometry
Inhibition of JAK1/JAK2 in human whole blood assessed as free fraction of IL6-induced STAT1 phosphorylation by flow cytometry
Inhibition of JAK1/TYK2 in human whole blood assessed as free fraction of IFNalpha-induced STAT3 phosphorylation by flow cytometry
Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFNalpha-induced STAT phosphorylation by flow cytometry
Assay data:10 Active, 7 Activity ≤ 1 µM, 11 Tested
Inhibition of human recombinant TYK2 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQID and ATP by mobility shift assay
Assay data:14 Active, 13 Activity ≤ 1 µM, 14 Tested
Inhibition of human recombinant JAK1 assessed as level of phosphorylation in presence of peptide substrate 5FAM-KKSRGDYMTMQUID and ATP by mobility shift assay
Assay data:13 Active, 12 Activity ≤ 1 µM, 14 Tested
Inhibition of human recombinant JAK2 assessed as level of phosphorylation in presence of peptide substrate FITC-KGGEEEEYFELVKK and ATP by mobility shift assay
Assay data:13 Active, 7 Activity ≤ 1 µM, 14 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on